Back to mobile site

More on NGNE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neurogene (NQ:NGNE)
Delayed: 30.86 -1.39 (4.31%)
Prev. Close $32.25  
Open$31.97 
52 Wk High$ 
52 Wk Low$ 
Day High$32.62 
Day Low$30.80 
P/E N/A  
EPS$ 
Volume118,370 

Friends, Peers and Foes (?): TSHA, BMRN, DNLI, DYN, LXEO (more...)

Jun 16, 2026 05:32 PM Form 4/A Neurogene Inc. For: Jun 14 Filed by: Woods Keith
Jun 16, 2026 05:32 PM Form 4/A Neurogene Inc. For: Jan 16 Filed by: Woods Keith
Jun 16, 2026 05:32 PM Form 4/A Neurogene Inc. For: Jun 12 Filed by: Woods Keith
Jun 16, 2026 05:30 PM Form 3/A Neurogene Inc. For: Dec 18 Filed by: Woods Keith
Jun 9, 2026 06:47 AM H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)
Jun 8, 2026 07:33 AM Form 8-K Neurogene Inc. For: Jun 08
Jun 8, 2026 07:31 AM Neurogene completes dosing in gene therapy trial for Rett syndrome
Jun 8, 2026 07:30 AM Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
Jun 4, 2026 04:41 PM Form 8-K Neurogene Inc. For: Jun 03
Jun 3, 2026 06:42 AM Rodman & Renshaw Starts Neurogene (NGNE) at Buy, PT $70
View All Articles

Entities mentioned with NGNE

View All Entities